Billionaire David Rubenstein: Private Equity Deals, Global Investing and Risk

Investor Tips
An interview with billionaire Private Equity titian and co-founder of The Carlyle Group, David Rubenstein. In this interview, David discusses private equity deals and investing in different countries. David also talks about risk and philanthropy.📚Books recommended by David Rubenstein are located at the bottom of the description❗

Like if you enjoyed
Subscribe for more:
Follow us on twitter:

Other great Private Equity investor videos:⬇

Steve Schwarzman reflects on Blackstone and His Life:

Billionaire Henry Kravis on Finance, Work Ethic and Life:

Billionaire Leon Black: Investment Strategy for Private Equity:

Video Segments:
0:00 Introduction
0:29 Pessimistic about the economy?
3:58 What are you seeing?
7:10 Dell deal?
9:55 Antitrust case?
10:36 US and Europe investments?
13:48 Buying distressed assets in Europe?
14:26 Robust future for Europe?
15:55 Cyprus good for investments?
17:18 Investing in China?
20:19 Biggest risks?
24:21 Moving past private equity?
27:03 Does the IPO move you towards a more short term orientation?
27:57 Why did you join the giving pledge?
32:00 Start of Q&A
32:13 How can emerging markets grow?
37:26 Private equity growth capital council?
40:20 What’s next for you?

David Rubenstein’s Recommended BooksđŸ”„(affiliate link)
The Hemingses of Monticello:

Interview Date: 28th May, 2013
Event: Partner Connect Events
Original Image Source:

Investors Archive has videos of all the Investing/Business/Economic/Finance masters. Learn from their wisdom for free in one place.

For more check out the channel.

Remember to subscribe, share, comment and like!

No advertising.


Products You May Like

Articles You May Like

Will The IRS Deny Your Claim For The Employee Retention Tax Credit?
Don’t Forget To Do Your Retirement Homework
Walkability As The Ultimate Amenity For Luxury Homebuyers
As Biden weighs a federal gas tax holiday, here’s what that could mean for prices at the pump
Fraud trial against Elizabeth Holmes’ partner at Theranos nears end